News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
860,274 Results
Type
Article (87393)
Company Profile (759)
Press Release (772096)
Multimedia
Podcasts (169)
Webinars (27)
Section
Business (233041)
Career Advice (4137)
Deals (39790)
Drug Delivery (134)
Drug Development (91241)
Employer Resources (202)
FDA (18276)
Job Trends (17396)
News (397354)
Policy (39924)
Tag
Academia (3004)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (124)
Alliances (56979)
ALS (143)
Alzheimer's disease (1679)
Antibody-drug conjugate (ADC) (228)
Approvals (18287)
Artificial intelligence (483)
Autoimmune disease (69)
Automation (25)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (158)
Biotechnology (484)
Bladder cancer (124)
Brain cancer (52)
Breast cancer (480)
Cancer (3811)
Cardiovascular disease (333)
Career advice (3553)
Career pathing (37)
CAR-T (242)
CDC (56)
Cell therapy (673)
Cervical cancer (32)
Clinical research (75303)
Collaboration (1364)
Company closure (4)
Compensation (929)
Complete response letters (59)
COVID-19 (2951)
CRISPR (81)
C-suite (570)
Cystic fibrosis (133)
Data (4267)
Decentralized trials (2)
Denatured (60)
Depression (109)
Diabetes (445)
Diagnostics (7085)
Digital health (36)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (229)
Drug pricing (187)
Drug shortages (36)
Duchenne muscular dystrophy (201)
Earnings (98750)
Editorial (54)
Employer branding (25)
Employer resources (171)
Events (132820)
Executive appointments (981)
FDA (20686)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (5)
Frontotemporal dementia (14)
Funding (1231)
Gene editing (173)
Generative AI (48)
Gene therapy (540)
GLP-1 (1013)
Government (5378)
Grass and pollen (7)
Guidances (337)
Healthcare (20937)
HIV (48)
Huntington's disease (37)
IgA nephropathy (55)
Immunology and inflammation (238)
Immuno-oncology (19)
Indications (52)
Infectious disease (3184)
Inflammatory bowel disease (185)
Inflation Reduction Act (15)
Influenza (93)
Intellectual property (184)
Interviews (815)
IPO (17925)
IRA (59)
Job creations (5196)
Job search strategy (2864)
Kidney cancer (15)
Labor market (74)
Layoffs (638)
Leadership (32)
Legal (10148)
Liver cancer (91)
Longevity (12)
Lung cancer (544)
Lymphoma (259)
Machine learning (29)
Management (66)
Manufacturing (631)
MASH (136)
Medical device (14858)
Medtech (14879)
Mergers & acquisitions (22731)
Metabolic disorders (1139)
Multiple sclerosis (137)
NASH (23)
Neurodegenerative disease (226)
Neuropsychiatric disorders (59)
Neuroscience (2699)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (57)
Obesity (555)
Opinion (310)
Ovarian cancer (124)
Pain (161)
Pancreatic cancer (166)
Parkinson's disease (239)
Partnered (30)
Patents (411)
Patient recruitment (299)
Peanut (57)
People (66222)
Pharmaceutical (144)
Pharmacy benefit managers (27)
Phase I (23221)
Phase II (32701)
Phase III (24597)
Pipeline (2660)
Policy (294)
Postmarket research (3554)
Preclinical (10482)
Press Release (72)
Prostate cancer (192)
Psychedelics (51)
Radiopharmaceuticals (282)
Rare diseases (657)
Real estate (7421)
Recruiting (78)
Regulatory (27944)
Reports (64)
Research institute (2688)
Resumes & cover letters (650)
Rett syndrome (15)
RNA editing (15)
RSV (70)
Schizophrenia (134)
Series A (205)
Series B (151)
Service/supplier (30)
Sickle cell disease (79)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4318)
State (2)
Stomach cancer (17)
Supply chain (99)
Tariffs (94)
The Weekly (107)
Vaccines (1037)
Venture capital (66)
Weight loss (392)
Women's health (58)
Worklife (21)
Date
Today (96)
Last 7 days (559)
Last 30 days (2414)
Last 365 days (33564)
2025 (25814)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1279)
Alabama (80)
Alaska (7)
Arizona (302)
Arkansas (14)
Asia (50918)
Australia (8952)
California (9326)
Canada (2826)
China (878)
Colorado (397)
Connecticut (417)
Delaware (260)
Europe (117020)
Florida (1370)
Georgia (312)
Hawaii (3)
Idaho (67)
Illinois (805)
India (50)
Indiana (455)
Iowa (19)
Japan (311)
Kansas (123)
Kentucky (38)
Louisiana (20)
Maine (77)
Maryland (1263)
Massachusetts (7015)
Michigan (309)
Minnesota (559)
Mississippi (4)
Missouri (118)
Montana (33)
Nebraska (26)
Nevada (106)
New Hampshire (76)
New Jersey (2575)
New Mexico (32)
New York (2543)
North Carolina (1400)
North Dakota (10)
Northern California (4198)
Ohio (293)
Oklahoma (21)
Oregon (50)
Pennsylvania (1942)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (47)
South Dakota (1)
Southern California (3564)
Tennessee (149)
Texas (1463)
United States (34505)
Utah (276)
Virginia (246)
Washington D.C. (83)
Washington State (805)
West Virginia (4)
Wisconsin (96)
Wyoming (1)
There are 860,274 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Biologics Market Size to Exceed USD 1,144.20 Billion by 2034 Amid Rising Demand for Monoclonal Antibodies, Vaccines, and Personalized Therapies
October 14, 2025
·
1 min read
Series B
Kailera Banks Massive $600M Raise For Phase III Obesity Study
Kailera’s lead asset, KAI-9531, elicited an average weight loss of more than 17% in a Phase III study in China. The biotech expects to launch a global late-stage program for the drug this year.
October 14, 2025
·
2 min read
·
Tristan Manalac
Alzheimer’s disease
Roche, Lilly Win First FDA Nod for Alzheimer’s Blood Test for Primary Care Use
Elecsys’ approval could help boost the uptake of currently approved Alzheimer’s disease therapies, including Biogen’s Eisai-partnered Leqembi, with CEO Chris Viehbacher recently noting that such biomarker-based tests could “remove some of the bottlenecks” in uptake.
October 14, 2025
·
2 min read
·
Tristan Manalac
Earnings
Thanks to Pfizer, Drug Pricing Clouds Begin To Clear as Q3 Earnings Roll Out
J&J reports today, just two weeks after Pfizer secured certainty on tariffs and drug pricing. Analysts expect to hear about plans from the rest of the industry during third period earnings calls.
October 14, 2025
·
5 min read
·
Annalee Armstrong
Manufacturing
Violations at Novo’s Indiana Plant ‘Unacceptable,’ FDA Says
Slapped with the most severe post-inspection classification, the state of Novo Nordisk’s Indiana manufacturing site could pose a problem for clients, including Regeneron and Scholar Rock.
October 14, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Oculis to Spotlight Transformative Late-Stage Pipeline at Eyecelerator and AAO 2025
October 14, 2025
·
11 min read
Press Releases
AGFA HealthCare Powers Enterprise Imaging Modernization Across North America
October 14, 2025
·
4 min read
Press Releases
Abalos Therapeutics Publishes in Cell Reports Medicine Validating ABX-001’s Potential to Overcome Cancer Immunotherapy Hurdles
October 14, 2025
·
4 min read
Press Releases
EVOQ Therapeutics Awarded $2 Million NIH Grant to Advance Therapies to Treat Celiac Disease - An Autoimmune Disease Impacting 2.4 Million Americans
October 14, 2025
·
2 min read
Press Releases
Visible Tumor Uptake and Recommended Dose Increase in Spago Nanomedicals’s Phase I/IIa Study Tumorad-01
October 14, 2025
·
4 min read
1 of 86,028
Next
